slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 27,331-27,360
Pages 1,371
Rows per page 30
Component
27,331-27,360 of 41,127
14
Includes footnotes referencing LTM data and reconciliation.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations 1 hit
02
Allarity Therapeutics | Investor Conference Presentation Deck | 23 slidesAllarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
02
Allego | Investor Presentation Deck | 50 slidesAllego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
02
Allego | Investor Presentation Deck | 50 slidesAllego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
03
Includes a map of European operations and key performance metrics.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
18
The table is segmented by region (European, North American, Asian) and lists specific brands/groups with their respective electrification percentage targets and target years.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
The slide uses a structured table to demonstrate market-wide shifts toward electrification, positioning Allego as a beneficiary.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations Loop · Why Now1 hit
32
Includes a footnote defining utilization rate and source.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
02
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Setup1 hit
33
Includes a disclaimer about compliance and separation of ads from clinical workflows.Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
39
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · Evidence1 hit
57
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations 1 hit
11
Includes two bar charts showing historical and estimated revenue and EBITDA.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
02
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
02
Aquestive Therapeutics | Results Presentation Deck | 14 slidesAquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations 1 hit
02
Aravive | Investor Presentation Deck | 39 slidesAravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
14
Includes specific clinical metrics (ORR, mPFS, mOS) comparing patients above and below the Minimal Efficacious Concentration (MEC).Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
The slide compares clinical outcomes (ORR, SD, CBR, PD) across four cohorts: two treatment groups and two historical control groups.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
22
The slide uses a process flow diagram to illustrate the trial structure.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
25
Data compares low vs high biomarker groups across different dosage cohorts.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
30
Data cutoff date is August 18, 2022. N=21 patients.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
02
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Situation & Context1 hit
09
The slide uses a horizontal bar chart format to represent clinical trial progress.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
14
The slide uses a waterfall-style comparison for pricing and a 2x2 grid for indication-specific growth strategies.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
20
The slide uses a combination of a timeline/map graphic and a bar chart to demonstrate market penetration and adoption speed.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
49
AstraZeneca | Investor Day Presentation Deck | 49 slidesAstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
02
Includes a specific date note at the bottom: September 9th, 2022.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
14
The slide uses a split-layout with a dark sidebar for summary metrics and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
20
The slide uses a combination of a problem overview, a global impact section, and a 'huge need' vertical timeline/list.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
Includes a summary table on the left and a clinical trial roadmap/process diagram on the bottom right.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit